Menu
Recruiting NCT06485700

Peers and Technology for Adherence, Access, Accountability, and Analytics (PT4A)

No phase Interventional Cardiovascular Disease Hypertension

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Peer Delivery of Medications, Health Information Technology (HIT) Platform.
Who it may be relevant to
Registry conditions: Cardiovascular Disease, Hypertension. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Kenya
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Peer-based medication delivery decreases the cost of transportation and the opportunity cost of travel while HIT can support peer activities by facilitating targeted adherence counseling, teleconsultation, synchronization of clinical care, and pharmacy activities. The investigators have implemented a pilot program of door-to-door peer-based medication delivery and HIT in western Kenya, and preliminary data indicate improved adherence and blood pressure. However, the effectiveness of this implementation strategy is not fully established. Therefore, the objective of the study is to use the PRECEDE-PROCEED framework to conduct transdisciplinary implementation research to test the hypothesis that integrating peer delivery of medications with HIT (PT4A) improves medication adherence and reduces blood pressure among patients with uncontrolled hypertension in western Kenya.

Detailed description

Aim 1 will evaluate the effectiveness of PT4A by conducting a two-arm cluster randomized controlled implementation research hybrid type 2 trial, comparing PT4A to control. The primary biological outcome is one-year change in systolic blood pressure. The primary adherence outcome is the pill count adherence ratio. The primary implementation outcome is fidelity. Secondary outcomes are blood pressure control, self-reported adherence, and RE-AIM metrics. Aim 2 will evaluate potential mechanistic relationships between implementation measures and outcomes. Sub Aim 2.1 will evaluate if trust in the health system and patient activation mediate the relationship between PT4A and the outcomes. Aim 3 will consist of cost-effectiveness, budget impact, and qualitative analyses to help inform adaptation of PT4A to other settings. The research will be conducted by a transdisciplinary team with diverse and complementary expertise. The investigators intend to add to existing knowledge of innovative and scalable strategies to improve medication adherence for global hypertension control.

Interventions

  • Other Peer Delivery of Medications
    Door-to-door peer delivery of medications within patients' communities will be implemented.
  • Other Health Information Technology (HIT) Platform
    The HIT platform provides: 1) tailored counseling strategies through decision support; 2) teleconsultation support for clinician-peer-patient interactions; 3) medication refill tracking to enhance accountability of the peer delivery process; and 4) analytics to improve medication supply chain by generating patient-level drug consumption data.

Primary outcome measures

  • Mean Change in SBP from Baseline to Month 12 [Time frame: Baseline, Month 12]
  • Pill Count Adherence Ratio (PCAR) at Month 12 [Time frame: Month 12]
  • Number of Patient E-Signatures [Time frame: Up to Month 12]
  • Number of Completed HIT Forms [Time frame: Up to Month 12]
Secondary outcome measures (3)
  • Mean Change in SBP from Baseline to Month 6 [Time frame: Baseline, Month 6]
  • Percentage of Participants with Controlled Blood Pressure (BP) at Month 6 [Time frame: Month 6]
  • Percentage of Participants with Controlled BP at Month 12 [Time frame: Month 12]

Eligibility criteria

Inclusion criteria

  • Adult participants enrolled in AMPATH's CDM Program with uncontrolled hypertension (SBP ≥ 140 or diastolic BP (DBP) ≥ 90)

Exclusion criteria

  • hypertensive emergency requiring immediate medical attention,
  • terminal illness, and
  • inability to provide informed consent.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Health services research

Study locations

Kenya · 3 centers
  • Study Site — Webuye
  • Study Site — Kitale
  • Study Site — Eldoret

Identifiers

NCT: NCT06485700 · 24-00277

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗